Created at	Source	Raw Value	Validated value
Oct. 7, 2021, 9:30 a.m.	oms	Proportion of SARS-COV-2 infection in household contacts between favipiravir PEP group compred with no treatment group 14 days Proportion/ Odd ratio/ Relative Risk Reduction	Proportion of SARS-COV-2 infection in household contacts between favipiravir PEP group compred with no treatment group 14 days Proportion/ Odd ratio/ Relative Risk Reduction